InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
+1.1%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Smith Mary L., Director. Officer active across 1 company, notably PTC Therapeutics, INC.. In total, 7 filings have been recorded. History available since 11 June 2021. The latest transaction was filed on 3 January 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
4,000 shares0Common StockSEC:0001415889-25-001026:0
4,000 shares0Common StockSEC:0001415889-24-004098:0
4,000 shares0Common StockSEC:0001415889-23-000668:0
3,200 shares0Common StockSEC:0001179110-22-000393:0
3,200 shares0Common StockSEC:0001179110-22-000393
1,650 shares0Common StockSEC:0001179110-21-006723
1,650 shares0Common StockSEC:0001179110-21-006723:0
7 of 7 declarations
About Smith Mary L.
Mary L. Smith serves as a Director of PTC Therapeutics, Inc. In this role, she participates in the governance of the company and strategic decision-making. Mary brings valuable expertise in the sector, thereby enhancing the strategic direction of PTC Therapeutics. Her commitment to innovation is an asset for the company.
